Norway Supplementary Protection Certificates

Supplementary Protection Certificates

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Country	Patent Number	Supplementary Protection Certificate	SPC Country	SPC Description	SPC Expiration
European Patent Office	3581654	2021038	Norway	PRODUCT NAME: LUMASIRAN; REG. NO/DATE: EU/1/20/1496 20201124
European Patent Office	2523731	2020012	Norway	PRODUCT NAME: OSILODROSTAT ELLER ET FARMASOEYTISK AKSEPTABELT SALT DERAV, INKLUDERT OSILODROSTAT DIHYDROGENFOSFAT; REG. NO/DATE: EU/1/19/1407 20200203
European Patent Office	2552902	2019019	Norway	PRODUCT NAME: DORAVIRIN ELLER ET FARMASOEYTISK AKSEPTABELT SALT DERAV; REG. NO/DATE: EU/1/18/1332/001-2 20181213
European Patent Office	3170818	2020025	Norway	PRODUCT NAME: EN KOMBINASJON AV (A) 3-(6-; REG. NO/DATE: EU/1/15/1059 20151210
European Patent Office	2666774	2020022	Norway	PRODUCT NAME: RELEBACTAM; EVENTUELT I FORM AV MONOHYDRAT OG IMIPENEM; REG. NO/DATE: EU/1/19/1420 20200219
European Patent Office	2379069	2020017	Norway	PRODUCT NAME: SIPONIMOD; REG. NO/DATE: EU/1/19/1414 20200127